About Services Profiles Press Contact

Reid Maclellan, M.D.

Chief Executive Officer

Cortina Health, Inc.

Chattanooga, TN, USA

Reid Maclellan

Simon Mackenzie-Smith

Bank of America Merrill Lynch

Susan Magrino Dunning

Susan Magrino Agency

Reid Maclellan’s Biography

View moreless

Reid Maclellan, MD is the Founder and CEO of Cortina Health, Inc.

Cortina Health is a healthcare technology company that offers a concierge level end-to-end telehealth skincare experience. By combining patent pending artificial intelligence with its national network of board-certified dermatologists, Cortina Health provides patients a superior quality of care from the comfort of their own home.

As an Adjunct Professor of Surgery at Harvard Medical School and Boston Children’s Hospital, Reid lectures on translational medical research. Reid serves on the board of DIAGNOS, a Canadian software company, and shares his expertise as an advisor to dermatology practice management group, Proactive Dermatology Group.

Reid is involved with philanthropic initiatives, including the Maclellan Foundation Inc, Christian Education Charitable Trust, and RL and KH Maclellan Foundation. He is a trustee of Gordon College and sits on the International Councilors of the Harvard Kennedy School Belfer Center for Science & International Affairs. He also serves as the chairman of Above the Clouds, a program... Reid Maclellan, MD is the Founder and CEO of Cortina Health, Inc.

Cortina Health is a healthcare technology company that offers a concierge level end-to-end telehealth skincare experience. By combining patent pending artificial intelligence with its national network of board-certified dermatologists, Cortina Health provides patients a superior quality of care from the comfort of their own home.

As an Adjunct Professor of Surgery at Harvard Medical School and Boston Children’s Hospital, Reid lectures on translational medical research. Reid serves on the board of DIAGNOS, a Canadian software company, and shares his expertise as an advisor to dermatology practice management group, Proactive Dermatology Group.

Reid is involved with philanthropic initiatives, including the Maclellan Foundation Inc, Christian Education Charitable Trust, and RL and KH Maclellan Foundation. He is a trustee of Gordon College and sits on the International Councilors of the Harvard Kennedy School Belfer Center for Science & International Affairs. He also serves as the chairman of Above the Clouds, a program that helps teens and children suffering from life-threatening illnesses. Reid was a Finance Committee Member of Massachusetts Medical Society and a member of the Alliance Charitable Foundation.

He co-hosts ‘The Voice of Healthcare,’ a podcast that discusses the major strides that can be achieved through healthcare technology. The podcast explores the intersection of disruptive technologies and the healthcare industry, among other related topics. Reid is invited to lecture across the world and publishes contributions to the field of vascular anomalies and lymphedema.

Reid graduated magna cum laude with a BS in psychology from the University of Alabama, Birmingham and an MD from the University of Alabama School of Medicine. He also earned a postdoctoral master's from Harvard Medical School. moreless

Reid Maclellan’s Newsfeed

Fast Company

World Changing Ideas Awards 2021: On The Rise (0-4 Years in Business) Finalists & Honorable Mentions

Cortina Health, Inc., led by CEO Reid Maclellan, M.D., was recognized as a company that has achieved incredible impact in the technology and innovation space. Spot, Cortina Health's all-in-one Teledermatology SolutionSpot is a technology that directs individuals to take photos of an area of concern, with the goal of providing patients superior quality of care and accurate results in teledermatology.

Healthcare Tech Outlook

Cortina Health: Utilizing A.I. to Restore the Care in Healthcare

Cortina Health's vision is simple: to restore the care in healthcare and improve patients and physicians' quality of life, beginning with the body's largest organ, our skin. To acomplish this goal, Cortina Health accompanies the patient through his/her entire skincare journey.

View News Archive

Reid Maclellan’s Background

Cortina Health, Inc.

Chief Executive Officer

Jan 2018 - Present

Chattanooga, TN, USA

Cortina Health is a healthcare technology company that offers a concierge level end-to-end telehealth skincare experience.

Boston Children's Hospital

Associate Director of Research | Department of Plastic Surgery

Jul 2014 - Jan 2018

Boston, MA, USA

Boston Children's Hospital is one of the largest pediatric medical centers in the United States and provides comprehensive health care services to children from birth to the age of 21.

View allHide

Reid Maclellan’s Gallery

Reid Maclellan for the cover of Heathcare Tech Outlook

reid maclellan of cortina global healthcare summit

Reid Maclellan speaks at the 2019 Voice of Healthcare Summit

Current Board Positions

DIAGNOS Inc.

Board of Directors

Mar 2018 - Present

Quebec City, CA

DIAGNOS is a Canadian software company that aims to improve the decision making process across a range of industries, including natural resources, healthcare, and entertainment, by combining contextual imaging and traditional data mining.

The Belfer Center for Science and International Affairs | Harvard Kennedy School

International Councilors

2020 - Present

Cambridge, MA, USA

The International Council is a prestigious group of senior business leaders and former government officials who care deeply about our mission to advance research, ideas, and leadership for a more secure, peaceful world.

Gordon College

Trustee

2018 - Present

Wenham, MA, USA

Gordon College is a private Christian college in Wenham, Massachusetts. The college offers 33 majors, 38 concentrations, and 21 interdisciplinary and pre-professional minors as well as graduate programs in education and music education.

Robert L. and Kathrina H. Maclellan Foundation

Board Member & Secretary

Jan 2013 - Present

Chattanooga, TN, USA

Founded in 1972, the Robert L. and Kathrina H. Maclellan Foundation aims to fulfill Robert’s wish which is that his estate be used for the greater good of his community. The foundation supports evangelical Christian ministries in the Chattanooga region and focuses on youth, family, education, leadership, and redemption.

The Maclellan Foundation, Inc.

Board of Directors

Jan 2013 - Present

Chattanooga, TN, USA

The Maclellan Foundation, Inc. is the most established of the Maclellan Family Foundations and was founded in 1945 by Robert J. Maclellan, his sister Dora Maclellan Brown, and his son Robert L. Maclellan. The foundation aims to encourage transformation, leadership and generosity by supporting and promoting the local church and community.

Christian Education Charitable Trust

Board Member & Trustee

Jan 2013 - Present

Chattanooga, TN, USA

The Maclellan’s Christian Education Charitable Trust explores new approaches to Christian education that incorporate technology and new developments to scale the impact of the faith.

View allHide

Previous Board Positions

Massachusetts Medical Society

Board of Trustees & Finance Committee

Jul 2013 - Sep 2017

Waltham, MA, USA

The Massachusetts Medical Society is one of the most established medical associations in the United States that consists of over 25,000 medical professionals, including physicians, medical students, and residents.

Massachusetts Medical Society and Alliance Charitable Foundation

Board of Directors

Jul 2013 - Sep 2017

Waltham, MA, USA

The Massachusetts Medical Society and Alliance Charitable Foundation are committed to improving the quality and accessibility of healthcare across Massachusetts.

Current Advisory Roles

PDG - Proactive Dermatology Group

Board of Advisors

Mar 2020 - Present

St. Petersburg, FL, USA

Proactive Dermatology Group (PDG) is a dermatology practice management group that offers a range of back-office services including administration, billing, compliance, payments and technology support.

Philanthropy

Above the Clouds

Chairman

Norwood, MA, USA

Above the Clouds offers flying programs for children and teens who have a serious illness or disability, are underserved, or facing other significant challenges. Its programs promote education and as an instrument for young people to feel a sense of excitement and accomplishment.

Media

The Voice of Healthcare

Co-host

Chattanooga, TN, USA

The Voice of Healthcare explores the growing impact of technology in healthcare (e.g., AI, voice-first, telehealth, venture capital). Co-hosted by Dr. Matt Cybulsky and Dr. Reid Maclellan. Communicating insightful expertise at the nexus of healthcare and technological advances in the global community, we cheerfully showcase instrumental, influential, and innovative ideas and experts.

The Voice of Healthcare, Episode 37: Nashville's Covid Czar, Dr. Alex Jahangir

Co-host

Jan 2021

Dr. Cybulsky (Founder, IONIA) and Dr. Maclellan (CEO, Cortina Health) meet with Dr. Alex Jahangir, Chairman of the Metro Nashville Board of Health as he coordinates the city's Covid 19 response and provides leadership across the Nashville metro area and state of Tennessee.

The Voice of Healthcare, Episode 36: The NHS and Entrepreneurship

Co-host

Jan 2021

Dr. Cybulsky (Founder, IONIA) and Dr. Maclellan (CEO, Cortina Health) meet with Prof Tony Young, the National Clinical Lead for Innovation of NHS England along with Dr. Abdullah Albeyatti, CEO of Medicalchain and MyClinic and Chair of Royal College of GPs, Yorkshire.

The Voice of Healthcare, Episode 35: The Digital Future of the Family Practitioner, AAFP

Co-host

Jan 2021

Dr. Cybulsky (Founder, IONIA) and Dr. Maclellan (CEO, Cortina Health) meet with Dr. Jacob Prunuske Assistant Dean of the Medical College of Wisconsin and Dr. Steve Waldren CMIO of the AAFP. We discuss the future of technology and the Family Practitioner.

The Voice of Healthcare, Episode 34: Bola.ai and Rushi Ganmukhi, Founder

Co-host

Jan 2021

Dr. Cybulsky (Founder, IONIA) and Dr. Maclellan (CEO, Cortina Health) meet with Rushi Ganmukhi, Founder of Bola.AI, an intelligent AI voice assistant for electronic medical records.

The Voice of Healthcare, Episode 33: Humanities, Liberal Arts, and Tech, The Blount Scholars Program

Co-host

Jan 2021

Dr. Cybulsky (Founder, IONIA) and Dr. Maclellan (CEO, Cortina Health) meet with Dr. Fred Whiting and Dr. Deborah Keene of the Blount Scholars Program at The University of Alabama. We discuss the impact of liberal arts upon the future of medicine and technology.

The Voice of Healthcare, Episode 32: Augmedix and Ian Shakil, Founder

Co-host

Jan 2021

Dr. Cybulsky (Founder, IONIA) and Dr. Maclellan (CEO, Cortina Health) meet with Ian Shakil (Founder, Augmedix) and Davin Lundquist MD (CMO, Augmedix). We discuss the advent of Augmedix, offerings, vision and strategy.

The Voice of Healthcare, Episode 31: Teladoc Health Chief Medical Officers

Co-Host

Nov 2020

Chattanooga, TN, USA

Dr. Cybulsky (Founder, IONIA) and Dr. Maclellan (CEO, Cortina Health) meet with Dr. Lew Levy and Dr. Bimal Shah of Teladoc Health. Robust offerings abound for the firm, and both leaders describe their missions, visions, and service orientations during the time of CV19 and future post-merger.

The Voice of Healthcare, Episode 30: The Voice of Healthcare Podcast: Heraeus Medical

Co-host

Sep 2020

Dr. Cybulsky (Founder, IONIA) and Dr. Maclellan (CEO, Cortina Health) meet with the Ash Malhatra and Huw Trotman with Heraeus Medical to discuss their digital journey in devices, orthopedics, and the care continuum. Outcomes, quality, satisfaction, and digital connectedness are discussed; don't miss it!

The Voice of Healthcare Podcast, Episode 29: Handwash Jukebox Alexa Skill

Co-host

Jul 2020

Dr. Cybulsky (Founder, IONIA) and Dr. Maclellan (CEO, Cortina Health) meet with the digital creators and Grammy Award winning artists associated with the Handwash Jukebox Alexa Skill. Featured in Rolling Stone, the Cannes Lions Festival of Creativity, and promoted by Amazon themselves, this skill impacts CV19 public health needs in the best way possible...music.

The Voice of Healthcare Podcast, Episode 28: COVID 19 Experts from The University of Alabama School of Medicine and Alabama College of Osteopathic Medicine

Co-host

Apr 2020

Dr. Cybulsky (Founder, IONIA) and Dr. Maclellan (CEO, Cortina Health) meet with Dr. Todd McCarty from UAB School of Medicine and Dr. Justin Hovey from the Alabama College of Ostepathic Medicine to discuss COVID 19, technologies being used in support of triage,treatment, tracking, and public health.

The Voice of Healthcare, Episode 27: The Voice of Healthcare Podcast: Greenwood Campbell and Dr. Arlene Astell

Co-host

Apr 2020

Dr. Cybulsky (Founder, IONIA) and Dr. Maclellan (CEO, Cortina Health) meet with Adam Greenwood of Greenwood Campbell and Dr. Arlene Astell from the Univ. of Reading to discuss their case study with residents of an Abbeyfield care home focused on alleviating loneliness. Located in the UK, subjects in their late 80s & 90s had never before encountered voice technologies. The results were astounding.

The Voice of Healthcare, Episode 26: Orthopedic Edition with Brigham Health, HSS, and Duke Health (cont’d)

Co-host

Apr 2020

Dr. Cybulsky (Founder, IONIA) and Dr. Maclellan (CEO, Cortina Health) continue their talk with three influential orthopedic surgeons: Dr. Steven Hass of the Hospital for Special Surgery, Dr. Antonia Chen of Brigham Health, and Dr. Thorsten Seyler with Duke Health. All three share their insights upon the COVID 19 response, telehealth and orthopedics.

The Voice of Healthcare, Episode 25: Orthopedic Edition with Brigham Health, HSS, and Duke Health

Co-host

Mar 2020

Chattanooga, TN, USA

Dr. Cybulsky (Founder, IONIA) and Dr. Maclellan (CEO, Cortina Health) talk to three influential orthopedic surgeons: Dr. Steven Hass of the Hospital for Special Surgery, Dr. Antonia Chen of Brigham Health, and Dr. Thorsten Seyler with Duke Health. All three experts share their knowledge on the current state of tech within orthopedics and what's to come.

The Voice of Healthcare, Episode 24: Dr. Lew Levy of Teladoc Health

Co-host

Feb 2020

Chattanooga, TN, USA

Dr. Cybulsky (Founder, IONIA) and Dr. Maclellan (CEO, Asclepius) talk to the CMO of Teladoc Health, Dr. Lew Levy. With incredible growth and over 4 million visits a year, Teladoc Health is an innovative virtual care leader. Dr Levy discusses the growth of virtual care, connecting patients and providers for the highest level of quality, and their relentless efforts to make care as delightful...

The Voice of Healthcare, Episode 23: Vanderbilt Health Edition

Co-host

Nov 2019

Chattanooga, TN, USA

Dr. Cybulsky (IONIA) and Dr. Maclellan (Asclepius) speak with Dr. Yaa Kumah-Crystal and Dan Albert of Vanderbilt University Medical Center about their voice product, VEVA. In this episode, Dr. Kumah-Crystal and Dan Albert describe the purpose of the tool, successes they’ve encountered with the product, and offer advice on the process of managing #voicefirst tool development projects.

View allHide

Publications

Liposuction for Swelling in Patients with Lymphedema

Senior Author

Nov 2017

Lymphedema is frequently a disabling consequence of cancer staging. Liposuction can considerably reduce swelling and may improve lymphatic drainage in an affected limb. This intervention is worthy of additional study...

Expression of Follicle-Stimulating Hormone Receptor in Vascular Anomalies

Lead Author

Mar 2014

The mechanism for the growth of infantile hemangioma and vascular malformations is unknown. Follicle-stimulating hormone secretion mirrors the life cycle of infantile hemangioma and increases during adolescence, when vascular malformations often progress. The purpose of this study was to determine whether vascular anomalies express the receptor for follicle-stimulating hormone...

Massive Localized Lymphedema: A Case-Control Study

Lead Author

Feb 2017

Massive localized lymphedema (MLL) is an area of skin and subcutaneous overgrowth associated with obesity. The purpose of this study was to determine whether MLL results from obesity-induced lymphedema (OIL) and to characterize the prevalence and risk factors for the condition. Massive localized lymphedema is a consequence of OIL and affects approximately 60% of obese patients with...

Obesity-Induced Lymphedema: Clinical and Lymphoscintigraphic Features

Senior Author

Jun 2015

The purpose of this study was to characterize obesity as a novel cause of lower extremity lymphedema. Fifty-one patients with a body mass index greater than 30 kg/m2 without any potential cause of lymphedema were evaluated with lymphoscintigraphy. Group 1 patients (n = 33) were at their maximum body mass index; individuals with lymphatic dysfunction had a greater body mass index (72.0 kg/m2)...

PIK3CA Activating Mutations in Facial Infiltrating Lipomatosis

Lead Author

Jan 2014

Facial infiltrating lipomatosis is a nonheritable disorder characterized by hemifacial soft-tissue and skeletal overgrowth, precocious dental development, macrodontia, hemimacroglossia, and mucosal neuromas. The authors tested the hypothesis that this condition is caused by a somatic mutation in the phosphatidylinositide-3 kinase (PI3K) signaling pathway, which has been indicted in other...

Study of 700 Referrals to a Lymphedema Program

Co-Author

Dec 2020

Lymphedema results from inadequate lymphatic function due to failure of lymphatic development or injury to a functioning lymphatic system. Patients suffer enlargement of the affected area, psychosocial morbidity, infection, and functional disability. The purpose of this study was to characterize the disease in a cohort of patients referred to a specialized center.

Adult-Onset Primary Lymphedema: A Clinical-Lymphoscintigraphic Study of 26 Patients

Co-Author

Dec 2019

Primary lymphedema results from the anomalous development of the lymphatic system that typically presents during infancy, childhood, or adolescence. Adult-onset primary lymphedema is rare and has not been studied. The purpose of this investigation was to characterize patients with primary lymphedema that developed after the pediatric time period to better understand the condition...

Lymphoscintigraphic Evaluation of Systemic Tracer Uptake in Patients With Primary Lymphedema

Co-Author

Apr 2019

Lymphoscintigraphy is used to confirm the diagnosis of lymphedema. One end point for the test is to ensure a patent thoracic duct by uptake of tracer in the organs. The purpose of this study was to evaluate transit of radiolabeled colloid to the organs to gain insight into the etiopathophysiology of primary lymphedema. Patients with primary lower extremity lymphedema often have pathways...

Primary Lymphedema of the Upper Extremities: Clinical and Lymphoscintigraphic Features in 23 Patients

Co-author

Feb 2019

Primary idiopathic lymphedema is an uncommon condition that typically affects the lower extremities. Patients have a malformed lymphatic system that causes subcutaneous fluid and adipose deposition. Rarely, the disease also has been described in the upper extremities. The purpose of this study was to investigate a cohort of patients with primary arm lymphedema to better understand the disease...

Vascular Malformation Enlargement During Menopause

Lead Author

Jul 2018

Vascular malformations enlarge overtime, particularly during adolescence when follicle-stimulating hormone (FSH) rises. Lesions contain the receptor for follicle-stimulating hormone. FSH also becomes elevated during menopause. We present a patient with a venous malformation of the lip that presented for the first time after she entered menopause which was temporally related to a significant...

Analysis of Follicle-Stimulating Hormone Receptor in Infantile Hemangioma

Lead Author

Apr 2018

The life cycle of infantile hemangioma (IH) and secretion of follicle-stimulating hormone (FSH) are identical. We previously have shown that IH contains the FSH receptor (FSHR). The purpose of this study was to identify which cell type(s) in IH expresses FSHR...

Factors Associated With Late Surgical Cancellations in Pediatric Plastic and Oral Surgery

Co-Author

Apr 2018

Surgical cancellations that occur within 1 day of the procedure (ie, late cancellations) disrupt the efficiency of the operating room. The aim of the present study was to identify the factors associated with late cancellations in a tertiary pediatric surgical practice. In our study, most late surgical cancellations were preventable or possibly preventable...

Association between extremity kaposiform hemangioendothelioma and lymphedema

Co-Author

Dec 2017

Kaposiform hemangioendotheliomas are pediatric vascular tumors that do not metastasize. We present a patient with a thigh kaposiform hemangioendothelioma successfully treated using a systemic corticosteroid during infancy who was diagnosed with lymphedema in the extremity 9 years later. The observation that extremity kaposiform hemangioendothelioma could possibly be associated with lymphedema...

Propranolol Treatment of Vascular Anomalies Other Than Infantile Hemangioma

Co-Author

Nov 2017

Oral propranolol has become first-line intervention for problematic infantile hemangioma (IH) that is not amenable to topical or intralesional therapies. Consensus data supporting its efficacy for other vascular anomalies does not exist. The purpose of this study was to determine the frequency and causes of propranolol use for vascular lesions other than IH. Propranolol commonly is used to...

Diagnostic Accuracy of Lymphoscintigraphy for Lymphedema and Analysis of False-Negative Tests

Co-Author

Jul 2017

Lymphedema is the chronic enlargement of tissue due to inadequate lymphatic function. Diagnosis is made by history and physical examination and confirmed with lymphoscintigraphy. The purpose of this study was to assess the accuracy of lymphoscintigraphy for the diagnosis of lymphedema and to determine characteristics of patients with false-negative tests. Lymphoscintigraphy is very sensitive...

Correlation Between Lymphedema Disease Severity and Lymphoscintigraphic Findings: A Clinical-Radiologic Study

Lead Author

Jun 2017

Lymphoscintigraphy is used to confirm the diagnosis of lymphedema; pathologic findings are abnormal transit time to regional nodes and dermal backflow. A universal protocol for the test does not exist. The purpose of this study was to determine whether the clinical severity of lymphedema correlates with lymphoscintigraphy findings. Clinical severity of lymphedema is not associated with...

Resolution of Primary Lymphedema: A Case Report

Co-Author

Feb 2017

Primary lymphedema is a rare, progressive disease that typically affects the lower extremity. The condition is not curable, and the limb enlarges over time because of subcutaneous fibroadipose deposition. We present a patient with clinical and radiographical evidence of resolution of primary lymphedema. This observation may provide greater insight into the pathophysiology of the disease...

Beckwith–Wiedemann Syndrome and Primary Lymphedema of the Lower Extremity

Co-Author

Oct 2016

Beckwith–Wiedemann syndrome is the most common genetic overgrowth syndrome. Patients with Beckwith–Wiedemann syndrome may have hemihypertrophy, but their lymphatic vasculature is intact. We present a child with Beckwith–Wiedemann syndrome and lower extremity enlargement thought to be due to hemihypertrophy that was instead diagnosed with primary lymphedema. There are many causes of leg...

Operative Treatment of Lymphedema Using Suction-Assisted Lipectomy

Co-Author

Sep 2016

Philadelphia, PA, USA

Surgical management of lymphedema includes removal of affected tissues (excisional procedures), or operations that create new lymphatic connections (physiologic procedures). The purpose of this study was to determine the efficacy of one type of excisional procedure, suction-assisted lipectomy, for extremity lymphedema. Suction-assisted lipectomy is an effective technique to reduce extremity...

An Experimental Study of Particulate Bone Graft for Secondary Inlay Cranioplasty Over Scarred Dura

Lead Author

Apr 2016

Inlay cranioplasty in children is challenging because autologous bone is limited. Cranial particulate bone graft effectively closes defects when placed over normal dura. The purpose of this study was to determine if particulate bone graft will ossify when used for secondary cranioplasty over scarred dura...

Combined Lymphedema and Capillary Malformation of the Lower Extremity

Lead author

Feb 2016

Primary lymphedema and capillary malformation are independent vascular malformations that can cause overgrowth of the lower extremity. We report a series of patients who had both types of malformations affecting the same leg. The condition is unique but may be confused with other types of vascular malformation overgrowth conditions (eg, Klippel–Trenaunay and Parkes Weber)...

Endothelial Cells from Capillary Malformations Are Enriched for Somatic GNAQ Mutations

Co-Author

Jan 2016

A somatic mutation in GNAQ (c.548G>A; p.R183Q), encoding Gαq, has been found in syndromic and sporadic capillary malformation tissue. However, the specific cell type containing the mutation is unknown. The purpose of this study was to determine which cells in capillary malformations have the GNAQ mutation. Endothelial cells in capillary malformations are enriched for GNAQ mutations...

Management of Vascular Anomalies and Related Conditions Using Suction-Assisted Tissue Removal

Co-Author

Oct 2015

Vascular anomalies and related conditions cause overgrowth of tissues. The purpose of this study was to determine the efficacy and safety of liposuction techniques for pediatric overgrowth diseases. Patients treated between 2007 and 2015 who had follow-up were reviewed. Seventeen patients were included; the median age was 12.7 years. The causes of overgrowth included infiltrating lipomatosis...

Management of Primary and Secondary Lymphedema

Lead Author

Aug 2015

Lymphedema is the chronic, progressive enlargement of tissue due to inadequate lymphatic function. Although lymphedema is a specific condition, patients with a large extremity are often labeled as having “lymphedema,” regardless of the underlying cause. The purpose of this study was to characterize referrals to a center to determine if lymphedema should be managed by specialists...

Obesity-induced Lymphedema Nonreversible following Massive Weight Loss

Senior author

Jul 2015

Lymphedema is the progressive enlargement of tissue due to inadequate lymphatic function. Obesity-induced lymphedema of the lower extremities can occur once a patient’s body mass index (BMI) exceeds 50. We report our first patient with obesity-induced lower extremity lymphedema who was followed prospectively before and after weight loss...

Obesity-Induced Lymphedema Clinical and Lymphoscintigraphic Features

Senior Author

Jun 2015

Philadelphia, PA, USA

The purpose of this study was to characterize obesity as a novel cause of lower extremity lymphedema. Fifty-one patients with a body mass index greater than 30 kg/m2 without any potential cause of lymphedema were evaluated with lymphoscintigraphy. Group 1 patients (n = 33) were at their maximum body mass index; individuals with lymphatic dysfunction had a greater body mass index (72.0 kg/m2) ...

Lymphatic and Other Vascular Malformative/Overgrowth Disorders Are Caused by Somatic Mutations in PIK3CA

Co-Author

Apr 2015

Somatic PIK3CA mutations are the most common cause of isolated LMs and disorders in which LM is a component feature. Five PIK3CA mutations account for most cases. The search for causal mutations requires sampling of affected tissues and techniques that are capable of detecting low-level somatic mosaicism because the abundance of mutant cells in a malformed tissue can be low...

False Negative Cytology in Large Thyroid Nodules

Co-Author

Jan 2015

Controversy exists regarding the accuracy of fine-needle aspiration (FNA) in large thyroid nodules. Recent surgical series have documented false-negative rates ranging from 0.7 to 13 %. We examined the accuracy of benign FNA cytology in patients with thyroid nodules ≥3 cm who underwent surgical resection and identified features characteristic of false-negative results...

Infantile Hemangioma: Treatment Rate During the Proliferating Phase

Co-Author

Sep 2014

Infantile hemangiomas affect 2% to 5% of children and are the most common tumor of infancy. The lesions grow rapidly during the first 9 months; 80% of their size is reached by approximately 5 months. After infancy, infantile hemangiomas shrink, and most have completed involution by 4 years. Infantile hemangiomas typically are small and nonproblematic and are simply observed as they enlarge...

Lymphedema

Lead Author

Aug 2014

Lymphedema is the chronic, progressive swelling of tissue due to inadequate lymphatic function. Over time, protein-rich fluid accumulates in the tissue, causing it to enlarge. Lymphedema is a specific disease and should not be used as a generic term for an enlarged extremity. The diagnosis is made by evaluating the history and physical examination, and can be confirmed with lymphoscintigraphy...

Hypercalcemia in the emergency department: a missed opportunity

Co-Author

Aug 2014

Primary hyperparathyroidism is surgically correctable and frequently presents with mild hypercalcemia. The symptoms of hyperparathyroidism are nonspecific often leading to a delay in diagnosis until patients present with an acute condition. Literature suggests that up to 20 per cent of patients presenting to the emergency department (ED) found to have hypercalcemia are ultimately diagnosed with...

Downregulation of RelA (p65) by Rapamycin Inhibits Murine Adipocyte Differentiation and Reduces Fat Mass of C57BL/6J Mice despite High Fat Diet

Co-Author

Jan 2014

London, UK

Rapamycin (RAPA) is a clinical immunosuppressive agent first reported in the literature in 1975 after its discovery in a soil sample from the island of Rapa Nui. Aside from the well-documented effects of RAPA on cell division and immunologic response, the literature reveals it to have negative effects on adipocyte and osteocyte differentiation as well. Understanding of the molecular effects of...

PIK3CA Activating Mutations in Facial Infiltrating Lipomatosis

Lead Author

Jan 2014

Philadelphia, PA, USA

Facial infiltrating lipomatosis is a nonheritable disorder characterized by hemifacial soft-tissue and skeletal overgrowth, precocious dental development, macrodontia, hemimacroglossia, and mucosal neuromas. The authors tested the hypothesis that this condition is caused by a somatic mutation in the phosphatidylinositide-3 kinase (PI3K) signaling pathway, which has been indicted in other...

Obesity-induced Upper Extremity Lymphedema

Co-Author

Oct 2013

Obesity increases the risk of upper extremity lymphedema following treatment for breast cancer and can cause lower extremity lymphatic dysfunction in extremely obese individuals. We report the first patient with obesity-induced upper extremity lymphedema. A 62-year-old man with a previous body mass index (BMI) of 105.6, presented with a BMI 60.3 following weight loss. He complained of...

Infantile hemangioma: clinical assessment of the involuting phase and implications for management

Co-author

Sep 2012

Philadelphia, PA, USA

Infantile hemangioma involutes during childhood; the tumor decreases in size and its color fades. Reconstructive procedures are often withheld until the lesion stops improving. The purpose of this study was to determine the age at which involution of infantile hemangioma ends, and factors that influence its regression. Most infantile hemangiomas do not improve significantly after 3.5 years of ...

View allHide

Awards & Endorsements

World Changing Ideas Awards 2021: On The Rise

Honorable Mention

2021

Cortina Health, led by CEO Reid Maclellan, M.D., was recognized as a company that has achieved incredible impact in the technology and innovation space. Spot, Cortina Health's all-in-one Teledermatology SolutionSpot is a technology that directs individuals to take photos of an area of concern, with the goal of providing patients superior quality of care and accurate results in teledermatology.

The Plastic Surgery Foundation

Bernard G. Sarnat Excellence in Grant Writing Award

2013

Dr. Maclellan was recognized with The Bernard G. Sarnat, MD, Excellence in Grant Writing Award for his exceptional research contribution to The Plastic Surgery Foundation's grant program.

View allHide

Academic Appointments

Harvard Medical School

Instructor of Surgery

Jul 2014 - Present

Boston, MA, USA

Founded in 1782, Harvard Medical School is the graduate medical school of Harvard University and is located in the Longwood Medical Area of Boston, Massachusetts.

Boston Children's Hospital

Instructor of Surgery

Jul 2014 - Present

Boston, MA, USA

Boston Children’s Hospital is a leading center for pediatric health care and is the primary pediatric program of Harvard Medical School.

View allHide

Speaking Engagements

Respada Global Healthcare Summit

Panel Member

Jul 2020

Dr. Maclellan, Founder and CEO of Cortina Health, took part in a panel titled 'Healthcare Technology Trends' at the 2020 Global Healthcare Summit presented by Respada. The panel included pioneers in the healthcare industry from around the world.

Reid Maclellan’s Education

Harvard Medical School

M.M. Sc. Vascular Anomalies

2011 - 2013

University of Tennessee College of Medicine Chattanooga

General Surgery Resident

2010 - 2011

View allHide